Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00019892
DRKS00019892
Not yet recruiting
Phase 4

Improvement of detection of clinically significant prostate cancer by combination of molecular urine markers and multiparametric MRI of the prostate

Klinik für Urologie Uniklinik Köln0 sites640 target enrollmentDecember 30, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC61Malignant neoplasm of prostate

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
C61
Sponsor
Klinik für Urologie Uniklinik Köln
Enrollment
640
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 30, 2019
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Klinik für Urologie Uniklinik Köln

Eligibility Criteria

Inclusion Criteria

  • •Life expectancy \> 10 years
  • •\- Clinical suspicion of prostate cancer (PSA \> 4\.0ng/ml and/or positive digitorectal examination)

Exclusion Criteria

  • •\- Prostate cancer in medical history
  • •\- Acute prostatitis in the last 6 months
  • •\- PSA \> 20 ng/ml
  • •\- Contraindicaitons for a mpMRI
  • •\- PSA affecting interventions (e.g. medication such as 5\-alpha reductase inhibitors, azaleas, bicalutamide etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Increasing diagnostic accuracy in patients with myoclonic disorders. Giant potential measurements with multichannel SSEPmyoclonusshakingtrembling10028037
NL-OMON32617Academisch Medisch Centrum80
Completed
Not Applicable
Development of a new biomarker for the detection of colorectal cancer using plasma concentrations of amino acids and metabolitesColorectal Cancer
JPRN-UMIN000029920Kyorin University School of Medicine The Third Department of Internal Medicine400
Completed
Not Applicable
Clinical verification of an improved assay of "NX-PVKA-R", which associated with des-gamma-carboxyprothrombin, for diagnosis of patients with hepatocellular carcinomaHepatocellular carcinoma
JPRN-UMIN000007196Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine25
Recruiting
Not Applicable
A study on improving the diagnostic performance of mild cognitive impairment using Multi-PLD AS
JPRN-jRCT1020210069Sasaki Makoto190
Active, not recruiting
Phase 1
Research to Improve the Detection and Treatment of Latent Tuberculosis Infection: Diagnostics (RID TB:Dx)A randomised trial to evaluate the effectiveness of a new C-Tb skin test to replace the current IGRA blood test for diagnosing latent TB infectio
EUCTR2019-002592-34-GBniversity College London1,705